AiThority February 25, 2020
The latest Healthtech M&A market report from Hampleton Partners, the international technology mergers and acquisitions advisor, reveals that boom times are back in healthtech M&A, along with a rapidly increasing appetite to apply Artificial Intelligence (AI) to solve many of medicine’s pressing problems.
The number of AI-related healthtech transactions has doubled every six months since the second half of 2017, reaching 10 per cent of all deals by the end of 2019.
Back to boom
Overall healthtech transaction volumes have seen a healthy rebound after dropping significantly in 2H2016 and 1H2017. Volumes increased by 14 per cent compared to 1H 2019 and 27 per cent compared to the same period last year.
The majority of recent disclosed healthtech transactions were...